Intco Medical Technology Co., Ltd.
300677
Rank in Stocks
#3956
Intco Medical Technology Co., Ltd. is a company dedicated to the development,... Intco Medical Technology Co., Ltd. is a company dedicated to the development, manufacturing, and worldwide distribution of both single-use medical products and durable medical equipment, serving markets within China and internationally. Their extensive product portfolio includes a variety of personal protective equipment like gloves, face masks, and shields, as well as essential clinical supplies such as ECG electrodes, medical apparel (e.g., isolation gowns), and hand hygiene solutions in both gel and spray forms. The company also produces specialized surgical components, including grounding pads, electrosurgical pencils, ESU cables, tip cleaners, and TENS electrodes. Beyond disposables, Intco Medical supplies a range of robust medical devices, notably mobility aids such as wheelchairs and scooters, along with other general medical apparatus. Their offerings further extend to temperature therapy items, emergency treatment provisions, products for maternal and infant care, and various home healthcare solutions. Established in 2009 and headquartered in Zibo, China, the company underwent a formal corporate name update in January 2020, maintaining its designation as Intco Medical Technology Co., Ltd.
Share Price
$6.36
Market Cap
$4.16B
Change (1 day)
-0.12%
Change (1 year)
8.75%
Country
CN
Trade Intco Medical Technology Co., Ltd. (300677)
Category
Healthcare
Revenue for Intco Medical Technology Co., Ltd. (300677)
Revenue in Jun 2026 TTM: $1.73B
According to Intco Medical Technology Co., Ltd. latest financial reports the company's current revenue (TTM) is $1.73B. In 2023 the company made a revenue of $977.41M an increase over the revenue in the year 2022 that was $958.82M. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Intco Medical Technology Co., Ltd. from 2013 to 2026
Revenue at the end of each year
| Year | Revenue | Change |
|---|---|---|
| 2026 (TTM) | $1.73B | 32.41% |
| 2024 | $1.30B | 33.49% |
| 2023 | $977.41M | 1.94% |
| 2022 | $958.82M | -62.47% |
| 2021 | $2.56B | 20.63% |
| 2020 | $2.12B | 608.08% |
| 2019 | $299.13M | 8.72% |
| 2018 | $275.13M | 2.26% |
| 2017 | $269.05M | 57.89% |
| 2016 | $170.41M | 10.88% |
| 2015 | $153.69M | 7.60% |
| 2014 | $142.83M | 21.47% |
| 2013 | $117.59M | 0.00% |
Revenue for similar companies or competitors
| Company | Revenue | Revenue Difference | Country |
|---|---|---|---|
| $11.03B | 538.72% |
US
|
|
| $34.74B | 1,910.71% |
FR
|
|
| - | - |
JP
|
|
| $20.84B | 1,106.26% |
US
|
|
| - | - |
CH
|
